Instalab
logoInstalab

IgG Subclasses

Blood Test
The closer look at your immune defenses when infections keep coming but your standard antibody test looks normal.
4.9 (3,538 reviews)
Tested by Quest Diagnostics
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a IgG Subclasses test?

This test is most useful if any of these apply to you.

Catching Every Bug Around
You get sinus, ear, or chest infections far more often than others around you, and routine tests have not explained it.
Told Your Basic Labs Are Normal
Your standard immune labs came back fine, but repeated infections hint at a gap a single antibody number can hide.
Living With Chronic Lung Issues
You have bronchiectasis or ongoing chest infections with no clear cause and want to know if weak antibodies contribute.
On Medication That Affects Immunity
You take a drug like rituximab or long-term steroids and want to check whether it is lowering your protective antibodies.

About IgG Subclasses

Your body makes one main class of infection-fighting antibody, called immunoglobulin G, or IgG. A standard test reports it as a single number, and that number can look completely normal while one of its four working parts runs low. This panel separates IgG into those four parts to find gaps a total reading hides.

That matters most if you catch sinus, ear, or chest infections far more often than the people around you. When basic labs come back normal but the infections keep coming, a specific weakness in one antibody subtype is one explanation worth checking. This panel is where that check begins.

What This Panel Reveals

IgG is not one uniform substance. It comes in four subtypes, numbered one through four by how much of each you normally carry. They look nearly identical but do different jobs, and the pattern across all four tells a story a single total cannot.

IgG1 and IgG3 handle most protein targets: the pieces of viruses, many bacteria, and vaccines built from proteins. IgG2 specializes in the sugar coatings that wrap certain bacteria, including the pneumonia and meningitis germs your body clears by recognizing that coating. A shortfall in one group hints at which kind of germ you may struggle to fight.

IgG4 is the rarest subtype and the hardest to read. It rises with long, repeated exposure to a substance and behaves in a calming, blocking way rather than an attacking one. Very low IgG4 is common in healthy people, and a low IgG4 on its own is not treated as a meaningful deficiency; expert guidelines base a subclass-deficiency diagnosis on IgG1, IgG2, or IgG3 and leave IgG4 out. A lopsided rise in IgG4, by contrast, points toward a separate inflammatory condition rather than a weak immune system.

Total IgG can stay in the normal range even when one subclass runs low, because the others can rise to fill the gap. That compensation is exactly why the split view catches problems the single number misses.

How to Read Your Results Together

No single subclass result means much on its own. The value is in the pattern, and in reading that pattern against your history of infections.

PatternWhat it may suggest
Low IgG2, often with low IgG4, plus repeated infections with sugar-coated bacteriaWeaker defense against these bacteria; the most established of the subclass patterns (though low IgG4 alone carries no weight)
Low IgG3, alone or with low IgG1The most common single subclass deficit in adults, though many people with it still respond normally to vaccines
Low IgG1 with a low or low-normal total IgGPoints beyond a subclass issue toward broader antibody deficiency that deserves fuller evaluation
An isolated low subclass with no unusual infectionsOften of little consequence, and may reflect normal variation more than disease

A low number is a clue, not a verdict. Whether it matters depends on whether your body can still make working antibodies, which is judged by your response to a vaccine rather than by the subclass level itself.

What to Do with Your Results

Confirm before you conclude. A single low subclass should be rechecked at least a month later, since values move and one draw can mislead. Interpret the repeat against age-specific ranges, because normal levels differ across the lifespan and between labs.

If a low result holds and you have a history of frequent infections, an allergist or immunologist is the right next step. The useful companion test is not another subclass panel but a functional one: your antibody response to a pneumonia vaccine, alongside total IgG, IgA (immunoglobulin A), and IgM (immunoglobulin M). Reviewing your medications matters too, since drugs such as rituximab, certain seizure medicines, and long steroid courses can lower these antibodies.

Milder patterns can slowly broaden into a larger antibody deficiency over years, so tracking every one to two years is reasonable when results are abnormal. A different situation is an out-of-proportion rise in IgG4, which points away from immune weakness and toward an inflammatory condition that usually needs imaging and often a tissue sample to sort out.

When Results Can Be Misleading

Several factors shift the whole panel at once. Reference ranges are not standardized across labs, so the same blood can read differently by method, and results should be compared only to the reporting lab's own ranges. Age changes everything: the protein-fighting subtypes reach adult levels earlier in childhood than the others, so children need age-matched interpretation. Recent infection, certain medications, and normal biological swings can all nudge values, which is why one abnormal result is a starting point, not an answer.

Frequently Asked Questions

References

8 studies
  1. Antony R Parker, Markus Skold, David B Ramsden, J Gonzalo Ocejo-vinyals, Marcos Lopez-hoyos, Stephen HardingLaboratory Medicine2017
  2. Gestur Vidarsson, Gillian Dekkers, Theo RispensFrontiers in Immunology2014
  3. Mollie N Carruthers, Arezou Khosroshahi, Toby Augustin, Vikram Deshpande, John H StoneAnnals of the Rheumatic Diseases2015
  4. Kristina Fruerlund Rasmussen, Ulrik Sprogoe, Christian Nielsen, Dana Bar Shalom, Kristian AssingImmunity, Inflammation and Disease2021
  5. Amara Khokar, Sudhir GuptaArchivum Immunologiae Et Therapiae Experimentalis2019